APA (7th ed.) Citation

A, T., G, T., T, T., K, Y., & A, I. (2026). Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan. Drugs - real world outcomes, 13(1), 101. https://doi.org/10.1007/s40801-025-00535-5

Chicago Style (17th ed.) Citation

A, Takami, Terashima G, Tajima T, Yamashita K, and Igarashi A. "Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan." Drugs - Real World Outcomes 13, no. 1 (2026): 101. https://doi.org/10.1007/s40801-025-00535-5.

MLA (9th ed.) Citation

A, Takami, et al. "Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan." Drugs - Real World Outcomes, vol. 13, no. 1, 2026, p. 101, https://doi.org/10.1007/s40801-025-00535-5.